NASDAQ : ONCO
Onconetix, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 0.586 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 2.31M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Onconetix, Inc. (ONCO) reported revenue of 645.82K USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 645.82K | 815.37K | 2.52M | 58.47K | ||
| Cost of Revenue | 126.60K | 182.46K | 1.47M | 1.19M | ||
| Gross Profit | 519.23K | 632.91K | 1.06M | -1.13M | ||
| Selling, General & Admin | 8.13M | 7.04M | 11.23M | 14.77M | 9.05M | 2.09M |
| Research & Development | 75.34K | -66.13K | 154.36K | 1.95M | 4.13M | 1.33M |
| Operating Expenses | 8.21M | 6.98M | 11.39M | 16.72M | 13.18M | 3.42M |
| Operating Income | -7.69M | -6.34M | -10.33M | -17.85M | -13.18M | -3.42M |
| Interest Expense | -310.95K | -751.00K | -1.41M | -671.62K | ||
| Interest & Investment Income | 2.00 | 2.00 | 18.00 | |||
| Other Non Operating Income (Expenses) | 15.68M | 9.76M | 1.42M | -91.97K | 61.41K | |
| EBT Excluding Unusual Items | 7.68M | 2.66M | -10.32M | -18.61M | -13.12M | -3.42M |
| Impairment of Goodwill | -8.62M | -11.51M | -32.35M | |||
| Asset Writedown | -13.81M | -14.69M | ||||
| Other Unusual Items | -9.26M | -5.18M | -3.26M | -4.12M | -300.00K | |
| Pretax Income | -10.20M | -14.03M | -59.74M | -37.42M | -13.42M | -3.42M |
| Income Tax Expense | 525.00 | 525.00 | -1.05M | -12.59K | ||
| Net Income | -10.20M | -14.03M | -58.69M | -37.41M | -13.42M | -3.42M |
| Preferred Dividends & Other Adjustments | 1.50M | 206.40K | 96.36K | 627.39K | ||
| Net Income to Common | -10.20M | -15.53M | -58.90M | -37.41M | -13.52M | -4.04M |
| Shares Outstanding (Basic) | 594.33K | 18.75K | ||||
| Shares Outstanding (Diluted) | 594.33K | 18.75K | ||||
| EPS (Basic) | -17.16 | -828.14 | ||||
| EPS (Diluted) | -17.16 | -828.14 | ||||
| Free Cash Flow | -10.31M | -9.68M | -10.52M | -23.16M | -8.68M | -2.05M |
| Free Cash Flow Per Share | -17.34 | -516.07 | ||||
| Gross Margin | 80.40% | 77.62% | 41.80% | |||
| Operating Margin | -1,190.29% | -778.16% | -409.30% | -30,526.38% | ||
| Profit Margin | -1,578.79% | -1,904.77% | -2,333.39% | -63,986.48% | ||
| Free Cash Flow Margin | -1,596.10% | -1,186.99% | -416.95% | -39,620.44% | ||
| EBITDA | -7.67M | -6.33M | -9.60M | -17.80M | -13.17M | -3.41M |
| D&A For EBITDA | 14.75K | 15.17K | 731.35K | 43.94K | 6.75K | 4.89K |
| EBIT | -7.69M | -6.34M | -10.33M | -17.85M | -13.18M | -3.42M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 5.94M | 5.22M | 646.50K | 4.55M | 25.75M | 1.93M |
| Cash & Short-Term Investments | 5.94M | 5.22M | 646.50K | 4.55M | 25.75M | 1.93M |
| Accounts Receivable | 2.35K | 296.87K | 25.72K | 149.73K | ||
| Other Receivables | 46.39K | 92.00K | 70.59K | 35.85K | 152.52K | |
| Receivables | 48.74K | 388.87K | 96.31K | 149.73K | 35.85K | 152.52K |
| Inventory | 210.45K | 149.96K | 64.08K | 364.05K | ||
| Prepaid Expenses | 316.37K | 307.29K | 143.38K | 770.15K | 469.23K | 234.55K |
| Other Current Assets | 757.65K | |||||
| Total Current Assets | 6.52M | 6.07M | 950.27K | 5.84M | 26.26M | 3.07M |
| Property, Plant & Equipment | 65.39K | 85.86K | 182.32K | 209.20K | 14.09K | 11.50K |
| Goodwill | 9.62M | 18.55M | 27.05M | 55.68M | ||
| Other Intangible Assets | 25.41M | |||||
| Long-Term Deferred Charges | 225.00K | 225.00K | 366.11K | |||
| Other Long-Term Assets | 17.42K | 38.62K | ||||
| Total Assets | 16.43M | 24.93M | 28.18M | 87.52M | 26.31M | 3.08M |
| Accounts Payable | 1.84M | 1.76M | 3.79M | 5.30M | 1.50M | 582.61K |
| Accrued Expenses | 249.61K | 341.88K | 888.99K | 2.07M | 2.28M | 809.28K |
| Short-Term Debt | 150.39K | 9.33M | 9.62M | |||
| Current Portion of Leases | 24.42K | 24.41K | 119.43K | 74.25K | ||
| Other Current Liabilities | 674.51K | 7.01M | 4.17M | 127.64K | 139.02K | 246.24K |
| Total Current Liabilities | 2.94M | 9.14M | 18.29M | 17.19M | 3.92M | 1.64M |
| Long-Term Debt | 118.86K | |||||
| Long-Term Leases | 12.31K | 24.36K | 74.29K | |||
| Pension & Post-Retirement Benefits | 280.88K | 556.30K | ||||
| Long-Term Deferred Tax Liabilities | 3.07M | |||||
| Other Long-Term Liabilities | 1.72K | 1.72K | 1.07M | 65.10M | ||
| Total Liabilities | 2.96M | 9.16M | 19.64M | 86.11M | 3.92M | 1.64M |
| Common Stock | 38.00 | 15.00 | 1.00 | 6.00 | 157.00 | 32.00 |
| Additional Paid-In Capital | 152.96M | 147.84M | 127.83M | 49.43M | 42.33M | 7.40M |
| Retained Earnings | -138.30M | -131.21M | -115.68M | -56.79M | -19.38M | -5.96M |
| Treasury Stock | -625.79K | -625.79K | -625.79K | -625.79K | -566.81K | |
| Comprehensive Income & Other | -568.72K | -231.03K | -2.97M | 2.38M | ||
| Total Common Equity | 13.47M | 15.76M | 8.54M | -5.60M | 22.39M | 1.45M |
| Minority Interest | 7.01M | |||||
| Shareholders' Equity | 13.47M | 15.76M | 8.54M | 1.40M | 22.39M | 1.45M |
| Total Liabilities & Equity | 16.43M | 24.93M | 28.18M | 87.52M | 26.31M | 3.08M |
| Total Debt | 187.13K | 48.77K | 9.45M | 9.89M | ||
| Net Cash (Debt) | 5.76M | 5.17M | -8.80M | -5.33M | 25.75M | 1.93M |
| Net Cash Per Share | 9.68 | 275.77 | ||||
| Filing Date Shares Outstanding | 3.95M | 71.69K | ||||
| Total Common Shares Outstanding | 3.79M | 31.20K | ||||
| Working Capital | 3.57M | -3.07M | -17.34M | -11.35M | 22.34M | 1.44M |
| Book Value Per Share | 3.55 | 505.28 | ||||
| Tangible Book Value | 3.85M | -2.78M | -18.51M | -86.69M | 22.39M | 1.45M |
| Tangible Book Value Per Share | 1.01 | -89.24 |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -10.20M | -14.03M | -58.69M | -37.41M | -13.42M | -3.42M |
| Depreciation & Amortization | 14.75K | 15.17K | 731.35K | 43.94K | 6.75K | 4.89K |
| Other Amortization | 119.12K | 124.08K | 1.14M | 671.37K | ||
| Loss (Gain) From Sale of Assets | 801.00 | 17.28K | 1.20K | |||
| Asset Writedown & Restructuring Costs | 8.62M | 11.51M | 46.16M | 14.95M | ||
| Stock-Based Compensation | 43.69K | 74.27K | 438.65K | 329.76K | 1.97M | 130.14K |
| Other Operating Activities | -6.91M | -4.97M | 1.27M | 6.21M | 202.51K | 22.24K |
| Change in Accounts Receivable | 27.82K | -268.69K | 116.68K | -62.29K | -114.96K | |
| Change in Inventory | -65.55K | -73.72K | -62.27K | -315.83K | ||
| Change in Accounts Payable | -733.52K | -1.09M | -1.48M | 3.37M | 1.09M | 336.71K |
| Change in Other Net Operating Assets | -1.23M | -983.39K | -118.69K | -1.37M | 1.47M | 992.87K |
| Operating Cash Flow | -10.31M | -9.68M | -10.50M | -13.58M | -8.68M | -2.04M |
| Capital Expenditures | -28.47K | -9.58M | -9.34K | -1.92K | ||
| Other Investing Activities | 934.04K | -23.33K | ||||
| Investing Cash Flow | -28.47K | -8.65M | -32.66K | -1.92K | ||
| Long-Term Debt Issued | 1.34M | 5.00M | ||||
| Long-Term Debt Repaid | -7.11M | -1.35M | -1.00M | |||
| Total Debt Repaid | -5.67M | -7.11M | -1.35M | -1.00M | ||
| Net Debt Issued (Repaid) | -4.56M | -5.78M | 3.65M | -1.00M | ||
| Issuance of Common Stock | 4.65M | 6.39M | 1.61M | 2.30M | 34.87M | |
| Repurchase of Common Stock | -58.98K | -566.81K | ||||
| Other Financing Activities | -348.00 | -926.00 | -400.72K | -205.09K | -1.77M | -334.19K |
| Financing Cash Flow | 15.64M | 14.45M | 6.74M | 1.04M | 32.53M | -334.19K |
| Foreign Exchange Rate Adjustments | 328.68K | -200.14K | -126.66K | -3.33K | ||
| Net Cash Flow | 5.66M | 4.57M | -3.91M | -21.20M | 23.82M | -2.38M |
| Free Cash Flow | -10.31M | -9.68M | -10.52M | -23.16M | -8.68M | -2.05M |
| Free Cash Flow Margin | -1,596.10% | -1,186.99% | -416.95% | -39,620.44% | ||
| Free Cash Flow Per Share | -17.34 | -516.07 | ||||
| Levered Free Cash Flow | -5.92M | -4.49M | -2.73M | -17.32M | -3.34M | -1.29M |
| Unlevered Free Cash Flow | -5.84M | -4.15M | -2.62M | -17.57M | -3.34M | -1.29M |
| Cash Interest Paid | 766.33K | 766.33K | 379.41K | |||
| Change in Working Capital | -2.00M | -2.42M | -1.54M | 1.62M | 2.56M | 1.21M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 2.22M | 2.43M | 5.22M | 3.64M | 17.02M | |
| Enterprise Value | -3.54M | 1.76M | 22.11M | 8.90M | -12.12M | |
| Last Close Price | 0.56 | 78.00 | 2,677.50 | 33,659.73 | 186,998.50 | |
| PS Ratio | 3.43 | 2.98 | 2.07 | 62.18 | ||
| PB Ratio | 0.16 | 0.15 | 0.61 | 2.59 | 0.76 | |
| P/TBV Ratio | 0.58 | 0.76 | ||||
| EV/Sales Ratio | 2.15 | 8.76 | 152.25 | |||
| Debt / Equity Ratio | 0.01 | 0.00 | 1.11 | 7.04 | ||
| Net Debt / Equity Ratio | -0.43 | -0.33 | 1.03 | 3.80 | -1.15 | -1.33 |
| Net Debt / EBITDA Ratio | 0.75 | 0.82 | -0.92 | -0.30 | 1.96 | 0.56 |
| Net Debt / FCF Ratio | 0.56 | 0.53 | -0.84 | -0.23 | 2.96 | 0.94 |
| Asset Turnover | 0.04 | 0.03 | 0.04 | 0.00 | ||
| Inventory Turnover | 0.70 | 1.71 | 6.86 | |||
| Quick Ratio | 2.04 | 0.61 | 0.04 | 0.27 | 6.58 | 1.27 |
| Current Ratio | 2.21 | 0.66 | 0.05 | 0.34 | 6.69 | 1.88 |
| Return on Equity (ROE) | -105.23% | -115.46% | -1,180.06% | -314.47% | -112.61% | -110.59% |
| Return on Assets (ROA) | -27.03% | -14.93% | -11.16% | -19.60% | -56.05% | -54.09% |
| Return on Capital Employed (ROCE) | -57.00% | -40.20% | -104.40% | -25.40% | -58.90% | -236.20% |
| Earnings Yield | -3,058.08% | -578.46% | -1,123.53% | -1,029.08% | -78.86% | |
| FCF Yield | -465.28% | -398.98% | -201.47% | -637.21% | -51.04% |